Amylx Pharmaceuticals Inc vs Angi Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Angi Inc trades at $4.5 (market cap $182.30M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 14.5× Angi Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Angi Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | ANGI | |
|---|---|---|
Market Cap | $2.64B | $182.30M |
Sector | Health | Media |
52-Week High | $24.19 | $18.46 |
52-Week Low | $7.82 | $4.49 |
Enterprise Value | $2.39B | $392.07M |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair
Read more on ANGI →